The Chin group researches and develops novel imaging agents and therapeutics with a focus on PET (Positron Emission Tomography) imaging. Located within the Cyclotron and Radiochemistry Facility at Stanford, we are involved in the arc of drug development all the way from research on the benchtop to translational first-in-man clinical studies, primarily using radiolabeled 18F and 11C tracers.
Meet our Team
The Chin group is comprised of radiochemists, inorganic chemists, molecular biologists, and production staff all investigating new innovative techniques to develop radiotracers and ligands for imaging various pathologies.
